Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Statistics

Total Valuation

OCUL has a market cap or net worth of $2.30 billion. The enterprise value is $2.04 billion.

Market Cap	2.30B
Enterprise Value	2.04B

Important Dates

The next confirmed earnings date is Tuesday, November 4, 2025, before market open.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

OCUL has 211.90 million shares outstanding. The number of shares has increased by 26.37% in one year.

Current Share Class	211.90M
Shares Outstanding	211.90M
Shares Change (YoY)	+26.37%
Shares Change (QoQ)	+6.56%
Owned by Insiders (%)	0.87%
Owned by Institutions (%)	61.19%
Float	183.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.50
Forward PS	36.86
PB Ratio	7.73
P/TBV Ratio	8.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	36.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.30.

Current Ratio	7.85
Quick Ratio	7.62
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.85

Financial Efficiency

Return on equity (ROE) is -81.83% and return on invested capital (ROIC) is -41.39%.

Return on Equity (ROE)	-81.83%
Return on Assets (ROA)	-35.01%
Return on Invested Capital (ROIC)	-41.39%
Return on Capital Employed (ROCE)	-69.81%
Revenue Per Employee	$203,588
Profits Per Employee	-$911,215
Employee Count	274
Asset Turnover	0.12
Inventory Turnover	45.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.82% in the last 52 weeks. The beta is 0.96, so OCUL's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+9.82%
50-Day Moving Average	12.07
200-Day Moving Average	9.53
Relative Strength Index (RSI)	45.04
Average Volume (20 Days)	2,646,514

Short Selling Information

The latest short interest is 13.59 million, so 6.41% of the outstanding shares have been sold short.

Short Interest	13.59M
Short Previous Month	13.56M
Short % of Shares Out	6.41%
Short % of Float	7.42%
Short Ratio (days to cover)	3.79

Income Statement

In the last 12 months, OCUL had revenue of $55.78 million and -$249.67 million in losses. Loss per share was -$1.44.

Revenue	55.78M
Gross Profit	-78.06M
Operating Income	-252.43M
Pretax Income	-249.67M
Net Income	-249.67M
EBITDA	-248.40M
EBIT	-252.43M
Loss Per Share	-$1.44

Balance Sheet

The company has $344.77 million in cash and $77.01 million in debt, giving a net cash position of $267.76 million or $1.26 per share.

Cash & Cash Equivalents	344.77M
Total Debt	77.01M
Net Cash	267.76M
Net Cash Per Share	$1.26
Equity (Book Value)	258.23M
Book Value Per Share	1.48
Working Capital	337.69M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-139.94%
Operating Margin	-452.53%
Pretax Margin	-447.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OCUL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.37%
Shareholder Yield	-26.37%
Earnings Yield	-10.83%
FCF Yield	n/a

Analyst Forecast

The average price target for OCUL is $22.33, which is 105.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.33
Price Target Difference	105.81%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	51.33%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a